Retatrutide pepide pen front view
Noventra Pharma Retatrutide packaging with multiple vials on a dark background
Retatrutide pepide pen kit

Noventra Retatrutide 64mg – 2ml Multi Dose Pen (200 Clicks)

R 3,150.00 R 3,000.00
Add to WishlistCompare

Noventra Retatrutide Research Overview

Noventra Retatrutide is a research peptide that has attracted significant scientific interest due to its multi-receptor design. Unlike compounds that target a single biological pathway, Retatrutide has been investigated for its interaction with multiple metabolic signaling pathways involved in energy regulation, nutrient utilization, and physiological adaptation.

Current scientific literature has explored Retatrutide in the context of metabolic health, body composition, energy balance, glucose regulation, and cardiometabolic research. Researchers continue to investigate how multi-pathway approaches may influence complex biological systems involved in metabolism.

Retatrutide remains an active area of clinical and preclinical investigation, with ongoing studies evaluating efficacy, safety, tolerability, and long-term outcomes across various research settings.

Key Areas of Scientific Interest

  • Metabolic regulation research
  • Energy balance investigations
  • Body composition studies
  • Glucose metabolism research
  • Cardiometabolic health investigations
  • Hormonal signaling research
  • Multi-receptor pathway exploration
  • Long-term metabolic outcome studies

Who May Be Interested in This Research?

This product may be of interest to individuals following developments in metabolic science, peptide research, endocrinology, longevity research, and emerging therapeutic technologies currently being investigated within the scientific community.

Key Features

Contains 64mg Retatrutide


Triple-action GLP-1, GIP, and glucagon receptor support


Supports appetite suppression and satiety


Assists advanced weight management protocols


Helps improve metabolic efficiency


Supports blood sugar regulation


Promotes progressive weekly dosing


Multi-dose pen with 200 clicks


Convenient subcutaneous administration


Designed for structured escalation protocols

Dosage & Usage

START


  • 2.5mg

  • Approximately 8 clicks

STEP


  • 5mg

  • Approximately 16 clicks

STEP


  • 7.5mg

  • Approximately 23 clicks

MAINTENANCE


  • 10mg

  • Approximately 31 clicks

STEP


  • 12.5mg

  • Approximately 39 clicks

STEP


  • 15mg

  • Approximately 47 clicks

MAX


  • 20mg

  • Approximately 63 clicks

Administration

Route of Administration


  • Subcutaneous injection

Typical Frequency


  • Once weekly

  • Administer on the same day each week

Maximum Dose


  • 20mg once weekly

Dosing Flexibility


  • Weekly administration day may be adjusted if at least 48 hours have passed between doses

Missed Dose Instructions


  • Administer within 5 days of the scheduled dose

  • If more than 5 days have passed, skip the missed dose and continue with the next scheduled dose

Continuation Protocol


  • Resume established once-weekly dosing schedule thereafter

Additional Notes


  • Rotate injection sites regularly

  • Designed for advanced metabolic support and appetite regulation

  • Formulated with premium excipients for stability and consistency
FAQ's & Tips

What is Retatrutide used for?

Retatrutide is commonly used to support appetite control, weight management, fat reduction, and metabolic health optimization.

How is Retatrutide administered?

The product is administered via subcutaneous injection using the multi-dose pen system.

How often is Retatrutide used?

The image indicates once-weekly administration.

What are the benefits of Retatrutide?

Potential benefits may include appetite suppression, reduced calorie intake, improved insulin sensitivity, enhanced fat metabolism, and weight management support.

Can Retatrutide be taken with food?

Yes. The image notes that Retatrutide may be administered with or without food.

What happens if a dose is missed?

The product advises administering the missed dose within 5 days. If more than 5 days have passed, skip the missed dose and continue with the next scheduled dose.

Research

Triple Receptor Agonist Activity

Retatrutide is a next-generation peptide researched for its simultaneous activation of GLP-1, GIP, and glucagon receptors involved in appetite regulation, metabolism, and energy expenditure.

Weight Management Research

Studies have explored Retatrutide for its potential role in significant body-weight reduction through appetite suppression and enhanced metabolic activity.

Metabolic & Glucose Support

Research suggests Retatrutide may help improve insulin sensitivity, blood glucose control, and metabolic flexibility through multi-pathway hormonal regulation.

Advanced Fat Loss Support

The peptide is also being investigated for its potential effects on energy expenditure and fat metabolism beyond traditional GLP-1-only therapies.

Research into metabolic peptide therapies remains ongoing and individual results may vary.

Reviews